Updates on Outcome of Board Meeting
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 20, 2015, has appointed the following Alternate Directors with effect from October 21, 2015:1. Mr. N. Rajaram (presently designated as Country Head and General Manager-Pharmaceutical Operations) as Alternate to Mr. J. Silvestre2. Mr. Lionel Guerin (presently designated as Chief Financial Officer) as Alternate to Mr. F. Briens.... Outcome of Board Meeting
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held October 20, 2015, re-appointed Dr. Shailesh Ayyangar as Managing Director of the Company for a further term of five years from October 25, 2015, subject to approval of the shareholders in General Meeting.Dr. Ayyangar had been designated Managing Director of the Company on October 25, 2005. He was subsequently re-appointed as Managing Director for a term of five years from October 25, 2010. Announces Q3 results & Limited Review Report for the quarter ended September 30, 2015
Sanofi India Ltd has announced the Un-Audited Standalone results for the quarter ended September 30, 2015 :The Company has posted a net profit of Rs. 725 million for the quarter ended September 30, 2015 as compared to Rs. 620 million for the quarter ended September 30, 2014. Total Income has increased from Rs. 5290 million for the quarter ended September 30, 2014 to Rs. 5952 million for the quarter ended September 30, 2015. Shareholding Pattern for September 30, 2015
Sanofi India Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Q3 results on Oct 20, 2015
Sanofi India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on held on October 20, 2015, for approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2015 (Q3). 20-year old Indian woman with Type 1 diabetes conquers White Mountains in Crete, Greece
Sanofi India Ltd has informed BSE regarding a Press Release dated October 01, 2015 titled "20-year old Indian woman with Type 1 diabetes conquers White Mountains in Crete, Greece".
Sanofi said to mull sale of bio-surgery, renal businesses
Sanofi is also considering options for its Merial animal health unit Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aberdeen Asse Management Asia Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Sanofi's combination diabetes drug hits goal in second late-stage trial
Sanofi said a second late-stage Phase III study of its LixiLan diabetes drug had met its main target, readying it for regulatory submissions by Q4 in the US. Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills
Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to develop a new type of immune system-boosting cancer medicine that could be given as tablets to fight both...